Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Glossary:TAG-00328-Com-egu

From GxPlex

Revision as of 17:29, 15 July 2026 by imported>GxPlexBot (Import from GxPlex Excel)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search


Glossary > Compliance

Compliance
Tag-ID TAG-00328-Com-egu
English Compliance / Regulatory compliance / Adherence
French Conformité / Conformité réglementaire / Respect des exigences
German Compliance / Einhaltung / Regulatorische KonformitÀt

References

 ScopeDocument partLanguageDocument
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 1 Part 2 6.HMSchedule 1

Part 2

6.
ENGBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004
ICH ICH E6 Guideline R3 (2025) Appendix B 12.3GAppendix B 12.3ENICH ICH E6 Guideline R3 (2025)
ICH ICH E6 Guideline R3 (2025) Appendix B 2.5GAppendix B 2.5ENICH ICH E6 Guideline R3 (2025)
ICH ICH E6 Guideline R3 (2025) GLOSSARY - Compliance (in relation to trials)GGLOSSARY - Compliance (in relation to trials)ENICH ICH E6 Guideline R3 (2025)
ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.5GIII. Annex 1 2.5ENICH ICH E6 Guideline R3 (2025)
ICH ICH E6 Guideline R3 (2025) III. Annex 1 3.12GIII. Annex 1 3.12ENICH ICH E6 Guideline R3 (2025)
ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 10.6MD10.6ENISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020
USA 21 CFR Part 812 09-Apr-2025 § 812.110 (b)MD§ 812.110 (b)ENUSA 21 CFR Part 812 09-Apr-2025
USA 21 CFR Part 812 09-Apr-2025 § 812.30 (b) - (c)MD§ 812.30 (b) - (c)ENUSA 21 CFR Part 812 09-Apr-2025
USA 21 CFR Part 812 09-Apr-2025 § 812.46 (a)MD§ 812.46 (a)ENUSA 21 CFR Part 812 09-Apr-2025
USA 45 CFR Part 46 09-Apr-2025 Subpart EGSubpart EENUSA 45 CFR Part 46 09-Apr-2025
WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 4.4 - IntroductionHM4.4 - IntroductionENWHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995